Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin.
Hatanaka K, Fuji S, Ikegame K, Kato R, Wake A, Hidaka M, Ito T, Inoue M, Nagatoshi Y, Takami A, Uike N, Sakamaki H, Yabe H, Morishima Y, Suzuki R, Atsuta Y, Fukuda T. Hatanaka K, et al. Among authors: kato r. Int J Hematol. 2012 Dec;96(6):773-80. doi: 10.1007/s12185-012-1209-4. Epub 2012 Nov 7. Int J Hematol. 2012. PMID: 23132596
Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K, Yoshihara S, Taniguchi Y, Kaida K, Inoue T, Okada M, Taniguchi K, Hasei H, Tamaki H, Fujioka T, Kato R, Soma T, Ogawa H. Ikegame K, et al. Among authors: kato r. Exp Hematol. 2011 Aug;39(8):880-90. doi: 10.1016/j.exphem.2011.05.007. Epub 2011 May 27. Exp Hematol. 2011. PMID: 21689724 Free article. Clinical Trial.
Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.
Yamasaki S, Heike Y, Mori S, Fukuda T, Maruyama D, Kato R, Usui E, Koido K, Kim S, Tanosaki R, Tobinai K, Teshima T, Takaue Y. Yamasaki S, et al. Among authors: kato r. Transpl Infect Dis. 2008 Jul;10(4):252-9. doi: 10.1111/j.1399-3062.2007.00291.x. Epub 2008 Jan 9. Transpl Infect Dis. 2008. PMID: 18194371
Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study.
Okada M, Yoshihara S, Taniguchi K, Kaida K, Ikegame K, Kato R, Tamaki H, Inoue T, Soma T, Kai S, Kato S, Ogawa H. Okada M, et al. Among authors: kato r, kato s. Biol Blood Marrow Transplant. 2012 Apr;18(4):633-9. doi: 10.1016/j.bbmt.2011.08.010. Epub 2011 Aug 23. Biol Blood Marrow Transplant. 2012. PMID: 21867667 Free article. Clinical Trial.
Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.
Tamaki H, Ikegame K, Yoshihara S, Kaida K, Yoshihara K, Inoue T, Kato R, Nakata J, Fujioka T, Soma T, Okada M, Ogawa H. Tamaki H, et al. Among authors: kato r. Transpl Infect Dis. 2019 Jun;21(3):e13073. doi: 10.1111/tid.13073. Epub 2019 Apr 1. Transpl Infect Dis. 2019. PMID: 30875143
Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation.
Tamaki H, Fujioka T, Ikegame K, Yoshihara S, Kaida K, Taniguchi K, Kato R, Tokugawa T, Nakata J, Inoue T, Yano A, Eguchi R, Okada M, Maruya E, Saji H, Ogawa H. Tamaki H, et al. Among authors: kato r. Eur J Haematol. 2012 Dec;89(6):497-500. doi: 10.1111/ejh.12017. Epub 2012 Oct 26. Eur J Haematol. 2012. PMID: 23033942
2,389 results